Pharmaceutical company asks SEC to investigate website allegations

US pharmaceutical company Valeant has called on the US Securities and Exchange Commission to investigate Citron Research, after the stock commentary website said that it had uncovered accounting fraud at Valeant, according to reports.

Unlock unlimited access to all Global Investigations Review content